AcelRx Pharmaceuticals Inc. (ACRX)

4.00
0.17 4.19
NASDAQ : Health Technology
Prev Close 4.17
Open 4.20
Day Low/High 3.95 / 4.25
52 Wk Low/High 1.55 / 5.75
Volume 674.29K
Avg Volume 536.60K
Exchange NASDAQ
Shares Outstanding 51.32M
Market Cap 210.42M
EPS -1.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Read All About It! Positive News on Four Positions

We still like all of these names after developments this week.

Stocks Under $10 Weekly Summary

During the week we scaled into two existing positions and added back shares of a former holding.

Stocks Under $10 Weekly Summary

During the week we added to our cannabis play Kush Bottles and took a nice win on J.Jill.

Stocks Under $10 Weekly Summary

Last week we trimmed USA Technologies and added LendingClub to the Bullpen.

Trimming This Specialty Pharmaceutical Name

ACRX has reached our price target, so we’re being disciplined.

AcelRx Announces FDA Acceptance Of NDA For DSUVIA

DSUVIA PDUFA date set for November 3, 2018

Stocks Under $10 Weekly Summary

We trimmed one position for a hefty gain last week, as the portfolio delivered very favorable performance on both an absolute and relative basis.

Stocks Under $10 Weekly Summary

We added 2 new positions during a week of solid performance for the portfolio.

Stocks Under $10 Weekly Summary

We added to three positions during a mixed week for the market.

Stocks Under $10 Weekly Summary

During a down week for the market, we exited one name and added to another.

Finally Significant News on a Health Care Position

Here’s our plan for AcelRx Pharmaceuticals leading up to earnings.

AcelRx Receives Positive CHMP Opinion For DZUVEO™ For Management Of Acute Moderate To Severe Pain In Medically Monitored Settings

DZUVEO is AcelRx's second developed sublingual sufentanil-based product to receive positive CHMP opinion, with Zalviso® already approved

Stocks Under $10 Weekly Summary

We initiated one position and closed out another last week.

Stocks Under $10 Weekly Summary

We added to two positions during a week when nearly all of our holdings moved higher.

Stocks Under $10 Weekly Summary

We exited one name and added to another during a wild week for stocks.

Stocks Under $10 Weekly Summary

The portfolio had several market outperformers last week and we took some profits in one high-flying position.

Stocks Under $10 Weekly Summary

We added 2 Bullpen names during a challenging week for the market.

Stocks Under $10 Weekly Summary

During a ‘noisy’ week for the portfolio, we added a small speculative position in a payment-processing name.

Trimming One Position, Adding to Another

We will sell shares of AcelRx Pharmaceuticals and buy more Black Box.

Stocks Under $10 Weekly Summary

The strength exhibited by the Russell 2000 paved the way for portfolio last week.

Everything Is Coming Up Roses

New price target on Kush Bottles plus a rocking employment report.

TheStreet Quant Rating: D- (Sell)